IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Diabetes Technology and Therapeutics

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

5.24

h-Index

2022-2023

 97

Rank

2022-2023

 986

SJR

2022-2023

 2.374

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Diabetes Technology and Therapeutics
Abbreviation Diabetes Technol. Ther.
Publication Type Journal
Subject Area, Categories, Scope Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1); Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q1)
h-index 97
Overall Rank/Ranking 986
SCImago Journal Rank (SJR) 2.374
Impact Score 5.24
Publisher Mary Ann Liebert Inc.
Country United States
ISSN 15209156, 15578593
Best Quartile Q1
Coverage History 1999-2022




Aim and Scope


Diabetes Technology & Therapeutics is the only peer-reviewed journal that focuses on the use of new devices, drug delivery systems, and software for managing diabetes.

The field of diabetes management is rapidly evolving because of the introduction of recently engineered devices and drugs. This journal focuses on emerging applications of bioengineering tools for diabetes management, including the use of optics, material science, controlled drug release, tissue engineering, informatics, modeling, genomics, imagery, and microelectronic mechanical systems (MEMS).

Diabetes Technology & Therapeutics fosters the development and use of new and emerging technologies to be applied to diabetes.


About Diabetes Technology and Therapeutics


Diabetes Technology and Therapeutics is a journal covering the technologies/fields/categories related to Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1); Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q1). It is published by Mary Ann Liebert Inc.. The overall rank of Diabetes Technology and Therapeutics is 986. According to SCImago Journal Rank (SJR), this journal is ranked 2.374. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 97. The best quartile for this journal is Q1.

The ISSN of Diabetes Technology and Therapeutics journal is 15209156, 15578593. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Diabetes Technology and Therapeutics is cited by a total of 2273 articles during the last 3 years (Preceding 2022).


Diabetes Technology and Therapeutics Impact IF 2022-2023


The Impact IF 2022 of Diabetes Technology and Therapeutics is 5.24, which is computed in 2023 as per its definition. Diabetes Technology and Therapeutics IF is decreased by a factor of 0.19 and approximate percentage change is -3.5% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Diabetes Technology and Therapeutics Impact IF 2023 Prediction


Impact IF 2022 of Diabetes Technology and Therapeutics is 5.24. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Diabetes Technology and Therapeutics. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 5.24
2021 5.43
2020 4.51
2019 4.26
2018 3.16
2017 1.65
2016 1.60
2015 1.50
2014 1.94

Diabetes Technology and Therapeutics h-index


  Table Setting

Diabetes Technology and Therapeutics has an h-index of 97. It means 97 articles of this journal have more than 97 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Diabetes Technology and Therapeutics ISSN


The ISSN of Diabetes Technology and Therapeutics is 15209156, 15578593. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Diabetes Technology and Therapeutics Rank and SCImago Journal Rank (SJR)


The overall rank of Diabetes Technology and Therapeutics is 986. According to SCImago Journal Rank (SJR), this journal is ranked 2.374. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Diabetes Technology and Therapeutics by Year


Year SJR
2023/2024 Coming Soon
2022 2.374
2021 2.660
2020 2.142
2019 1.819
2018 1.800
2017 1.735
2016 1.361
2015 1.245
2014 1.332

Ranking of Diabetes Technology and Therapeutics by Year


Year Ranking
2023/2024 Coming Soon
2022 986
2021 746
2020 1171
2019 1559
2018 1645
2017 1768
2016 2781
2015 3233
2014 2803

Diabetes Technology and Therapeutics Publisher


Table Setting

Diabetes Technology and Therapeutics is published by Mary Ann Liebert Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 1999-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Diabetes Technology and Therapeutics is Diabetes Technol. Ther.. This abbreviation ('Diabetes Technol. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Diabetes Technology and Therapeutics


If your research field is/are related to Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1); Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Diabetes Technology and Therapeutics?

Diabetes Technology and Therapeutics latest impact IF is 5.24. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 5.43 (2021) and 1.50 (2015), respectively, in the last 9 years. Moreover, its average IS is 3.25 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Diabetes Technology and Therapeutics?

The Diabetes Technology and Therapeutics has an SJR (SCImago Journal Rank) of 2.374, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 2.660 in 2021 and the lowest being 1.245 in 2015. Furthermore, the average SJR of the Diabetes Technology and Therapeutics over the previous 9-year period stands at 3.25.


What's the latest h-index of the Diabetes Technology and Therapeutics?

The latest h-index of the Diabetes Technology and Therapeutics is 97.


Who's the publisher of the Diabetes Technology and Therapeutics?

The Diabetes Technology and Therapeutics is published by the Mary Ann Liebert Inc., with its country of publication being the United States.


What's the current ranking of the Diabetes Technology and Therapeutics?

The Diabetes Technology and Therapeutics is currently ranked 986 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 746 in 2021 and its lowest position of 3233 in 2015.


What's the abbreviation or short name for the Diabetes Technology and Therapeutics?

The standard ISO4 abbreviation for the Diabetes Technology and Therapeutics is Diabetes Technol. Ther..


Is the "Diabetes Technology and Therapeutics" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Diabetes Technology and Therapeutics is classified as a journal that the Mary Ann Liebert Inc. publishes.


What's the scope or major areas of the Diabetes Technology and Therapeutics?

The Diabetes Technology and Therapeutics encompasses the following areas:

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medical Laboratory Technology
  • Medicine (miscellaneous)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Diabetes Technology and Therapeutics?

The Diabetes Technology and Therapeutics is assigned the following International Standard Serial Numbers (ISSN): 15209156, 15578593.


What's the best quartile of the Diabetes Technology and Therapeutics?

The best quartile for the Diabetes Technology and Therapeutics is Q1 (2022).


What's the coverage history of the Diabetes Technology and Therapeutics?

The Diabetes Technology and Therapeutics coverage history can be summarized as follows: 1999-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Business: Theory and Practice journal 13414 Vilnius Gediminas Technical University 21 2.47
Journal of Field Archaeology journal 5639 Maney Publishing 43 2.38
Mathematical Modelling and Analysis journal 11315 Vilnius Gediminas Technical University 27 1.75
Discourse journal 6621 Routledge 59 2.11
Child and Family Social Work journal 8628 Wiley-Blackwell Publishing Ltd 67 2.20
Population Review journal 17841 Sociological Demography Press 13 0.73
Exploration Geophysics journal 16383 Taylor and Francis Ltd. 48 1.17
Proceedings of the International Semiconductor Conference, CAS conference and proceedings 25734 Institute of Electrical and Electronics Engineers Inc. 16 0.00
Archives of the Balkan Medical Union journal 23243 Balkan medical union 10 0.24
Consulting engineer Barrington journal 24079 Cahners Pub. Co. 0 0.00

Check complete list




Year wise Impact Score (IS) of Diabetes Technology and Therapeutics

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 5.24
2021 5.43
2020 4.51
2019 4.26
2018 3.16
2017 1.65
2016 1.60
2015 1.50
2014 1.94



Top Journals/Conferences in Endocrinology

Lancet Diabetes and Endocrinology,The
Elsevier Ltd. | United Kingdom

Nature Reviews Endocrinology
Nature Publishing Group | United Kingdom

Endocrine Reviews
The Endocrine Society | United States

Nature Metabolism
Springer Berlin | Germany

Diabetes Care
American Diabetes Association Inc. | United States

Diabetologia
Springer Verlag | Germany

Metabolism: Clinical and Experimental
W.B. Saunders Ltd | United Kingdom

Obesity Reviews
Wiley-Blackwell Publishing Ltd | United Kingdom

Diabetes
American Diabetes Association Inc. | United States

Cytokine and Growth Factor Reviews
Elsevier BV | United Kingdom

See All

Top Journals/Conferences in Endocrinology, Diabetes and Metabolism

Lancet Diabetes and Endocrinology,The
Elsevier Ltd. | United Kingdom

Nature Reviews Endocrinology
Nature Publishing Group | United Kingdom

Endocrine Reviews
The Endocrine Society | United States

Nature Metabolism
Springer Berlin | Germany

Diabetes Care
American Diabetes Association Inc. | United States

Diabetologia
Springer Verlag | Germany

Metabolism: Clinical and Experimental
W.B. Saunders Ltd | United Kingdom

Obesity Reviews
Wiley-Blackwell Publishing Ltd | United Kingdom

Diabetes
American Diabetes Association Inc. | United States

Cytokine and Growth Factor Reviews
Elsevier BV | United Kingdom

See All

Top Journals/Conferences in Medical Laboratory Technology

Current Protocols in Cytometry
John Wiley & Sons Inc. | United States

Archives of Pathology and Laboratory Medicine
Taylor and Francis Ltd. | United States

Current Protocols
John Wiley & Sons Inc. | United States

Forensic Science International: Digital Investigation
Elsevier Ltd. | United Kingdom

Altex
Springer International Publishing AG | Germany

Journal of Clinical Laboratory Analysis
Wiley-Liss Inc. | United States

Histochemistry and Cell Biology
Springer Verlag | Germany

Microscopy Research and Technique
Wiley-Liss Inc. | United States

SLAS Technology
SAGE Publications Inc. | United States

Applied Immunohistochemistry and Molecular Morphology
Lippincott Williams and Wilkins Ltd. | United States

See All

Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

See All